Impact of cancer diagnosis and treatment on glycaemic control among individuals with colorectal cancer using glucose-lowering drugs

2016 ◽  
Vol 53 (5) ◽  
pp. 727-735 ◽  
Author(s):  
Marjolein M. J. Zanders ◽  
Myrthe P. P. van Herk-Sukel ◽  
Ron M. C. Herings ◽  
Lonneke V. van de Poll-Franse ◽  
Harm R. Haak
2015 ◽  
Vol 18 (7) ◽  
pp. A437
Author(s):  
MM Zanders ◽  
MP van Herk-Sukel ◽  
RM Herings ◽  
LV van de Poll-Franse ◽  
H Haak

Metabolites ◽  
2021 ◽  
Vol 11 (3) ◽  
pp. 159
Author(s):  
Yao Peng ◽  
Yuqiang Nie ◽  
Jun Yu ◽  
Chi Chun Wong

Colorectal cancer (CRC) is one of the leading cancers that cause cancer-related deaths worldwide. The gut microbiota has been proved to show relevance with colorectal tumorigenesis through microbial metabolites. By decomposing various dietary residues in the intestinal tract, gut microbiota harvest energy and produce a variety of metabolites to affect the host physiology. However, some of these metabolites are oncogenic factors for CRC. With the advent of metabolomics technology, studies profiling microbiota-derived metabolites have greatly accelerated the progress in our understanding of the host-microbiota metabolism interactions in CRC. In this review, we briefly summarize the present metabolomics techniques in microbial metabolites researches and the mechanisms of microbial metabolites in CRC pathogenesis, furthermore, we discuss the potential clinical applications of microbial metabolites in cancer diagnosis and treatment.


2020 ◽  
Vol 158 (6) ◽  
pp. S-1514
Author(s):  
Michael Poulson ◽  
Andrea M. Madiedo ◽  
Tracey Dechert ◽  
Jason Hall

Sign in / Sign up

Export Citation Format

Share Document